In vitro activity of the siderophore monosulfactam BAL30072 against meropenem-non-susceptible Acinetobacter baumannii

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 5, 2012, Pages 1167-1169

  Higgins, Paul G ^a   Stefanik, Danuta ^a   Page, Malcolm G P ^b   Hackel, Meredith ^c   Seifert, Harald ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b BASILEA PHARMACEUTICA INTERNATIONAL LTD   (Switzerland)

^c Division of Microbiology   (United States)

Author keywords

Aztreonam; Carbapenems; Oxacillinase; Tigecycline

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; AZTREONAM; BACTERIAL ENZYME; BAL 300072; CEFEPIME; COLISTIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; RIFAMPICIN; SIDEROPHORE MONOSULFACTAM; SULTAMICILLIN; TIGECYCLINE; TOBRAMYCIN; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BROTH DILUTION; CONTROLLED STUDY; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; UPREGULATION;

ACINETOBACTER BAUMANNII; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; GENE EXPRESSION; HUMANS; MICROBIAL SENSITIVITY TESTS; MONOBACTAMS; THIAZOLES; THIENAMYCINS;

EID: 84859602519     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks009     Document Type: Article

References (18)

1. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008; 21: 538-82.
2. Poirel L, Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 2006; 12: 826-36.
3. Higgins PG, Dammhayn C, Hackel M et al. Global spread of carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother 2010; 65: 233-8.
4. Coyne S, Courvalin P, Perichon B. Efflux-mediated antibiotic resistance in Acinetobacter spp. Antimicrob Agents Chemother 2011; 55: 947-53.
5. OXA-58 in carbapenem-resistant Acinetobacter baumannii isolated from a hospitalized patient. Antimicrob Agents Chemother 2010; 54: 5021-7.
6. Giannouli M, Cuccurullo S, Crivaro V et al. Molecular epidemiology of multidrug-resistant Acinetobacter baumannii in a tertiary care hospital in Naples, Italy, shows the emergence of a novel epidemic clone. J Clin Microbiol 2010; 48: 1223-30.
7. Li J, Rayner CR, Nation RL et al. Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2006; 50: 2946-50.
8. Page MGP, Dantier C, Desarbre E. In vitro properties of BAL30072, a novel siderophore sulfactam with activity against multiresistant Gram-negative bacilli. Antimicrob Agents Chemother 2010; 54: 2291-302.
9. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-first Informational Supplement M100-S21. CLSI, Wayne, PA, USA, 2011.
10. Landman D, Quale JM, Mayorga D et al. Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has returned. Arch Intern Med 2002; 162: 1515-20.
11. Kohlenberg A, Brummer S, Higgins PG et al. Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in a German university medical centre. J Med Microbiol 2009; 58: 1499-507.
12. Stoeva T, Higgins PG, Savov E et al. Nosocomial spread of OXA-23 and OXA-58 β-lactamase-producing Acinetobacter baumannii in a Bulgarian hospital. J Antimicrob Chemother 2009; 63: 618-20.
13. Nemec A, Krizove L, Maixnerova M et al. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II. J Antimicrob Chemother 2008; 62: 484-9.
14. Kim CK, Lee Y, Lee H et al. Prevalence and diversity of carbapenemases among imipenem-nonsusceptible Acinetobacter isolates in Korea: emergence of a novel OXA-182. Diagn Microbiol Infect Dis 2010; 68: 432-8.
15. Perez F, Hujer AM, Hujer KM et al. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2007; 51: 3471-84.
16. Hornsey M, Ellington MJ, Doumith M et al. AdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumannii. J Antimicrob Chemother 2010; 65: 1589-93.
17. Mushtaq S, Warner M, Livermore D. Activity of the siderophore monobactam BAL30072 against multiresistant non-fermenters. J Antimicrob Chemother 2010; 65: 266-70.
18. Russo TA, Page MGP, Beanan JM et al. In vivo and in vitro activity of the siderophore monosulfactam BAL30072 against Acinetobacter baumannii. J Antimicrob Chemother 2011; 66: 867-73.